Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
2.
Rev Med Interne ; 42(9): 625-632, 2021 Sep.
Artigo em Francês | MEDLINE | ID: mdl-33676780

RESUMO

The management of acute pancreatitis is now fairly codified, with specific recommendations developed by expert groups. These recommendations deal in particular with the minimum initial assessment, recognized severity scores, initial medical management with hyperhydration, preventive anticoagulation, early refeeding, delays in imaging and management of complications. In this work, we have tried to bring together the various recommendations, articles and studies dealing with this subject, based more particularly on European recommendations, in order to guide the management of acute pancreatitis in current practice.


Assuntos
Pancreatite , Doença Aguda , Diagnóstico por Imagem , Humanos , Pancreatite/diagnóstico , Pancreatite/epidemiologia , Pancreatite/terapia
3.
ANZ J Surg ; 89(7-8): 955-956, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31069925

RESUMO

We describe the combined application of a transabdominal wall sheath tunnel, 'pre-close' purse-string sutures and manual external support of the iliac artery to facilitate introduction of an 18F sheath for endovascular exclusion of a 6-cm thoracic aortic aneurysm.


Assuntos
Aneurisma da Aorta Torácica/cirurgia , Procedimentos Endovasculares/métodos , Artéria Ilíaca , Parede Abdominal , Idoso , Feminino , Humanos
6.
Med Mycol ; 56(6): 668-678, 2018 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-29228380

RESUMO

Data regarding the epidemiology and diagnosis of invasive aspergillosis in the critically ill population are limited, with data regarding elderly patients (≥75 years old) even scarcer. We aimed to further compare the epidemiology, characteristics and outcome of elderly versus nonelderly critically ill patients with invasive aspergillosis (IA) Prospective, international, multicenter observational study (AspICU) including adult intensive care unit (ICU) patients, with a culture and/or direct examination and/or histopathological sample positive for Aspergillus spp. at any site. We compared clinical characteristics and outcome of IA in ICU patients using two different diagnostic algorithms. Elderly and nonelderly ICU patients with IA differed in a number of characteristics, including comorbidities, clinical features of the disease, mycology testing, and radiological findings. No difference regarding mortality was found. According to the clinical algorithm, elderly patients were more likely to be diagnosed with putative IA. Elderly patients had less diagnostic radiological findings and when these findings were present they were detected late in the disease course. The comparison between elderly survivors and nonsurvivors demonstrated differences in clinical characteristics of the disease, affected sites and supportive therapy needed. All patients who were diagnosed with proven IA died. Increased vigilance combined with active search for mycological laboratory evidence and radiological confirmation are necessary for the timely diagnosis of IA in the elderly patient subset. Although elderly state per se is not a particular risk factor for mortality, a high SOFA score and the decision not to administer antifungal therapy may have an impact on survival of elderly patients.


Assuntos
Aspergilose/diagnóstico , Unidades de Terapia Intensiva/estatística & dados numéricos , Infecções Fúngicas Invasivas/diagnóstico , Idoso , Antifúngicos/uso terapêutico , Aspergilose/diagnóstico por imagem , Aspergilose/tratamento farmacológico , Aspergilose/mortalidade , Causas de Morte , Estudos de Coortes , Estado Terminal/mortalidade , Estado Terminal/terapia , Europa (Continente) , Análise Fatorial , Feminino , Humanos , Unidades de Terapia Intensiva/normas , Infecções Fúngicas Invasivas/diagnóstico por imagem , Infecções Fúngicas Invasivas/tratamento farmacológico , Infecções Fúngicas Invasivas/mortalidade , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco , Resultado do Tratamento
7.
BMC Infect Dis ; 16(1): 559, 2016 10 12.
Artigo em Inglês | MEDLINE | ID: mdl-27729010

RESUMO

BACKGROUND: Among septic patients admitted to the intensive care unit (ICU), early recognition of those with the highest risk of death is of paramount importance. Since clinical judgment is sometimes uncertain biomarkers could provide additional information likely to guide critical illness management. We evaluated the prognostic value of soluble Triggering Receptor Expressed by Myeloid cells 1 (sTREM-1), procalcitonin (PCT) and leucocyte surface expression of CD64. METHODS: This was a prospective cohort study, which included 190 septic patient admitted to the ICU in two hospitals. Blood samples for biomarker measurements were obtained upon admission and thereafter. The Simplified Acute Physiology Score (SAPS) II and the Sequential Organ Failure Assessment (SOFA) score were calculated. The primary outcome was all-cause death in the ICU. RESULTS: The mortality rate reached 25.8 %. The best predictive value of the three biomarkers was obtained with baseline sTREM-1, although clinical scores outperformed this. Accuracy was greater in patients without prior exposure to antibiotics and in those with proven bacterial infection. Adding sTREM-1 levels to SAPS II increased its specificity to 98 %. The soluble TREM-1 level, core temperature and SAPS II value were the only independent predictors of death after adjustment for potential confounders. A decrease in sTREM-1 with time was also more pronounced in survivors than in non-survivors. CONCLUSIONS: sTREM-1 was found to be the best prognostic biomarker among those tested. Both baseline values and variations with time seemed relevant. Although SAPS II outperformed sTREM-1 regarding the prediction of ICU survival, the biomarker could provide additional information.


Assuntos
Glicoproteínas de Membrana/sangue , Células Mieloides/metabolismo , Receptores Imunológicos/sangue , Sepse/sangue , Adulto , Idoso , Biomarcadores/sangue , Calcitonina/sangue , Feminino , Humanos , Unidades de Terapia Intensiva , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Admissão do Paciente , Prognóstico , Modelos de Riscos Proporcionais , Estudos Prospectivos , Curva ROC , Receptores de IgG/sangue , Sepse/diagnóstico , Sepse/mortalidade , Resultado do Tratamento , Receptor Gatilho 1 Expresso em Células Mieloides
8.
Ann Thorac Surg ; 102(6): 2028-2035, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27457833

RESUMO

BACKGROUND: The development of a postdissection aortic arch aneurysm after open ascending aortic replacement for type A dissection places the patient at increased risk for an open operation due to the need for redo sternotomy and total arch replacement. We conducted a computed tomography-based feasibility study to assess what proportion of these patients would be anatomically suitable for branched endograft repair of an arch aneurysm. We also aimed to identify ways to tailor the index operation to increase suitability for future endovascular repair. METHODS: Our study was conducted at the Aortic Centre, Lille University Hospital, Lille, France. Postoperative images were assessed for patients after open replacement of the ascending aorta for acute type A dissection in this center between 2009 and 2015 to determine suitability for use of an aortic arch inner-branched device. RESULTS: The assessment found 52 of 73 patients (71.2%) were anatomically suitable for treatment with the aortic arch inner-branched device. The only cause for absolute exclusion from suitability was the absence of a proximal landing zone in the ascending aorta. Reasons for this were the ascending aortic graft being too short (71.4%), the presence of a major kink in the graft (23.8%), and the graft diameter being too large (4.8%). CONCLUSIONS: Approximately 70% of patients with arch aneurysm formation after open ascending aortic replacement for type A dissection are anatomically suitable for treatment with the aortic arch inner-branched device. In the future, surgeons will be able to fashion the prosthetic graft at the time of the index operation to ensure it fulfills criteria for an adequate proximal landing zone.


Assuntos
Aneurisma da Aorta Torácica/cirurgia , Dissecção Aórtica/cirurgia , Implante de Prótese Vascular , Prótese Vascular , Procedimentos Endovasculares , Stents , Adulto , Idoso , Idoso de 80 Anos ou mais , Dissecção Aórtica/diagnóstico , Aneurisma da Aorta Torácica/diagnóstico , Estudos de Viabilidade , Feminino , França , Humanos , Masculino , Pessoa de Meia-Idade , Seleção de Pacientes , Desenho de Prótese , Reoperação , Tomografia Computadorizada por Raios X , Resultado do Tratamento
9.
Eur J Clin Microbiol Infect Dis ; 35(3): 489-95, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26753994

RESUMO

We investigated the positivity rate, the detection rates for non-covered pathogens and the therapeutic impact of microbiological samples (MS) in community-acquired pneumonia (CAP), nursing home-acquired pneumonia (NHAP) and hospital-acquired pneumonia (HAP) in elderly hospitalised patients. Patients aged 75 years and over with pneumonia and hospitalised between 1/1/2013 and 30/6/2013 in the departments of medicine (5) and intensive care (1) of our university hospital were included. Microbiological findings, intra-hospital mortality and one-year mortality were recorded. Among the 217 patients included, there were 138 CAP, 56 NHAP and 23 HAP. MS were performed in 89.9, 91.1 and 95.6 % of CAP, NHAP and HAP, respectively. Microbiological diagnosis was made for 29, 11.8 and 27.3 % of patients for CAP, NHAP and HAP, respectively (p = 0.05). Non-covered pathogens were detected for 8 % of CAP, 2 % of NHAP and 13.6 % of HAP (p = 0.1). The antimicrobial spectrum was significantly more frequently reduced when the MS were positive (46.7 % vs. 10.8 % when MS were negative, p = 10(-7)). The MS positivity rate was significantly lower in NHAP than in CAP and HAP. MS revealed non-covered pathogens in only 2 % of NHAP. These results show the poor efficiency and weak clinical impact of MS in the management of pneumonia in hospitalised older patients and suggest that their use should be rationalised.


Assuntos
Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/microbiologia , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/microbiologia , Pneumonia/diagnóstico , Pneumonia/microbiologia , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Anti-Infecciosos/uso terapêutico , Infecções Comunitárias Adquiridas/mortalidade , Infecções Comunitárias Adquiridas/terapia , Infecção Hospitalar/mortalidade , Infecção Hospitalar/terapia , Gerenciamento Clínico , Feminino , Mortalidade Hospitalar , Hospitalização , Hospitais , Humanos , Masculino , Casas de Saúde , Pneumonia/mortalidade , Pneumonia/terapia , Estudos Retrospectivos , Índice de Gravidade de Doença , Resultado do Tratamento
10.
Am J Public Health ; 104(12): e49-55, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25320874

RESUMO

Suicide and other self-directed violence deaths are likely grossly underestimated, reflecting inappropriate classification of many drug intoxication deaths as accidents or unintentional and heterogeneous ascertainment and coding practices across states. As the tide of prescription and illicit drug-poisoning deaths is rising, public health and research needs would be better satisfied by considering most of these deaths a result of self-intoxication. Epidemiologists and prevention scientists could design better intervention strategies by focusing on premorbid behavior. We propose incorporating deaths from drug self-intoxication and investigations of all poisoning deaths into the National Violent Death Reporting System, which contains misclassified homicides and undetermined intent deaths, to facilitate efforts to comprehend and reverse the surging rate of drug intoxication fatalities.


Assuntos
Overdose de Drogas/mortalidade , Overdose de Drogas/prevenção & controle , Intoxicação/mortalidade , Intoxicação/prevenção & controle , Vigilância da População , Prevenção do Suicídio , Causas de Morte , Feminino , Humanos , Masculino , Suicídio/estatística & dados numéricos , Terminologia como Assunto , Estados Unidos/epidemiologia
11.
Minerva Anestesiol ; 79(12): 1396-405, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23719654

RESUMO

Despite the availability of broad-spectrum antifungal agents, fungal sepsis remains an issue in Intensive Care Unit (ICU) patients. In terms of occurrence rates, the most important fungal infections are invasive candidiasis and invasive pulmonary aspergillosis. Early diagnosis is essential to optimize the chances of survival. As clinical rules based on risk factor assessment lack specificity, early initiation of antifungal therapy depends on fast and reliable diagnostics. Blood cultures or histopathologic evidence is the gold standard but blood cultures lack sensitivity and biopsy sampling may include substantial risk in critically ill patients. Non-culture-based diagnosis tools have therefore arisen as a smart way to detect earlier and/or more accurately the patients with on going fungal infection. For diagnosing invasive candidiasis, three assays (beta-D-glucan and mannan antigen detection, and polymerase chain reaction) yield promising predictive values, albeit that specificity remains an issue. In the absence of biopsies, invasive pulmonary aspergillosis can be diagnosed in nonneutropenic ICU patients by galactomannan antigen detection in broncho-alveolar lavage fluid. Aspergillus colonization of the respiratory tract can be discriminated from invasive disease by means of a clinical algorithm with high sensitivity but only moderate specificity. The incidence of invasive candidiasis has been stable over the past decades, but an alarming trend towards more non-albicans Candida species and reduced susceptibility is observed. Given the problematic diagnosis of invasive aspergillosis no reliable trend data are available. Outcome following fungal sepsis remains cumbersome. Given the availability of potent antifungal agents any progress in survival is likely to come from a more timely diagnosis.


Assuntos
Unidades de Terapia Intensiva , Micoses/terapia , Sepse/terapia , Antifúngicos/uso terapêutico , Cuidados Críticos , Humanos , Micoses/diagnóstico , Micoses/epidemiologia , Sepse/diagnóstico , Sepse/epidemiologia , Resultado do Tratamento
12.
Intensive Care Med ; 38(1): 145-52, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22127479

RESUMO

PURPOSE: Since the 2005 French law on end of life and patients' rights, it is unclear whether practices have evolved. We investigated whether an intensive communication strategy based on this law would influence practices in terms of withholding and withdrawing treatment (WWT), and outcome of patients hospitalised in intensive care (ICU). METHODS: This was a single-centre, two-period study performed before and after the 2005 law. Between these periods, an intensive strategy for communication was developed and implemented, comprising regular meetings and modalities for WWT. We examined medical records of all patients who died in the ICU or in hospital during both periods. RESULTS: In total, out of 2,478 patients admitted in period 1, 678 (27%) died in the ICU and 823/2,940 (28%) in period 2. In period 1, among patients who died in the ICU, 45% died subsequent to a decision to WWT versus 85% in period 2 (p < 0.01). Among these, median time delay between ICU admission and initiation of decision-making process was significantly different (6-7 days in period 1 vs. 3-5 days in period 2, p < 0.05). Similarly, median time from admission to actual WWT decision was significantly shorter in period 2 (11-13 days in period 1 vs. 4-6 days in period 2, p < 0.05). Finally, median time from admission to death in the ICU subsequent to a decision to WWT was 13-15 days in period 1 versus 7-8 days in period 2, p < 0.05. Reasons for WWT were not significantly different between periods. CONCLUSION: Intensive communication brings about quicker end-of-life decision-making in the ICU. The new law has the advantage of providing a legal framework.


Assuntos
Unidades de Terapia Intensiva , Comunicação Interdisciplinar , Padrões de Prática Médica , Assistência Terminal/legislação & jurisprudência , Idoso , Tomada de Decisões , Feminino , França/epidemiologia , Mortalidade Hospitalar , Humanos , Masculino , Auditoria Médica , Pessoa de Meia-Idade , Suspensão de Tratamento/legislação & jurisprudência
13.
Intensive Care Med ; 38(1): 55-61, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22127481

RESUMO

PURPOSE: Burnout syndrome (BOS) has frequently been reported in healthcare workers, and precipitating factors include communication problems in the workplace and stress related to end-of-life situations. We evaluated the effect of an intensive communication strategy on BOS among caregivers working in intensive care (ICU). METHODS: Longitudinal, monocentric, before-and-after, interventional study. BOS was evaluated using the Maslach Burnout Inventory (MBI) and depression using the Centre for Epidemiologic Studies Depression Scale (CES-D) in 2007 (period 1) and 2009 (period 2). Between periods, an intensive communication strategy on end-of-life practices was implemented, based on improved organisation, better communication, and regular staff meetings. RESULTS: Among 62 caregivers in the ICU, 53 (85%) responded to both questionnaires in period 1 and 49 (79%) in period 2. We observed a significant difference between periods in all three components of the MBI (emotional exhaustion, p = 0.04; depersonalization p = 0.04; personal accomplishment, p = 0.01). MBI classified burnout as severe in 15 (28%) caregivers in period 1 versus 7 (14%) in period 2, p < 0.01, corresponding to a 50% risk reduction. Symptoms of depression as evaluated by the CES-D were present in 9 (17%) caregivers in period 1 versus 3 (6%) in period 2, p < 0.05, corresponding to a risk reduction of almost 60%. CONCLUSION: The implementation of an active, intensive communication strategy regarding end-of-life care in the ICU was associated with a significant reduction in the rate of burnout syndrome and depression in a stable population of caregiving staff.


Assuntos
Unidades de Terapia Intensiva , Comunicação Interdisciplinar , Corpo Clínico Hospitalar/psicologia , Estresse Psicológico/prevenção & controle , Assistência Terminal , Adulto , Feminino , França , Hospitais Universitários , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Adulto Jovem
14.
Arch Gen Psychiatry ; 68(10): 1050-7, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21646567

RESUMO

CONTEXT: Suicides are prone to misclassification during death ascertainment procedures. This problem has generated frequent criticism of the validity of suicide mortality statistics. OBJECTIVE: To employ an external measure of the validity of cause-of-death statistics (ie, national autopsy rates) and to examine potential misclassification of suicide across countries from Europe to Central and Northern Asia. DESIGN: Cross-national analysis. SETTING: Thirty-five countries. PARTICIPANTS: Aggregated mortality data. MAIN OUTCOME MEASURES: Data from 35 countries during the period from 1979 to 2007 were used to analyze the association of suicide rates with autopsy rates and death rates of undetermined and ill-defined causes, respectively. Analyses were cross-sectional and longitudinal. RESULTS: Cross-sectionally, a 1% difference in autopsy rates among nations was associated with a suicide rate difference of 0.49 per 100,000 population. Longitudinally, a 1% decrease in the autopsy rate aligned with a decrease of 0.42 per 100,000 population in the suicide rate. These cross-sectional and longitudinal associations were robust after adjustment for unemployment, degree of urbanization, and prevalence of undetermined or ill-defined deaths. Associations strengthened when analyses were confined to 19 European Union member countries. CONCLUSION: Autopsy rates may spatially and temporally affect the validity of suicide mortality statistics. Caution should be exercised in comparing international suicide rates and evaluating interventions that target suicide rate reduction.


Assuntos
Autopsia/estatística & dados numéricos , Suicídio/estatística & dados numéricos , Causas de Morte , América Central/epidemiologia , Estudos Transversais , Europa (Continente)/epidemiologia , Humanos , Estudos Longitudinais , América do Norte/epidemiologia , Análise de Regressão , Reprodutibilidade dos Testes , Estatísticas Vitais
16.
J Antimicrob Chemother ; 47(1): 33-42, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11152429

RESUMO

An experimental Streptococcus pneumoniae pneumonia model in rabbits was used to assess the efficacy of amoxycillin, erythromycin and a new ketolide, telithromycin (HMR 3647). The MICs of amoxycillin, erythromycin and HMR 3647 for the three clinical S. pneumoniae strains used were, respectively, (mg/L): 0.01, 16 and 0.02 (strain 195); 2, 0.25 and 0.02 (strain 16089); 8, >64 and 0.02 (strain 11724). Antibiotic therapy reproduced human serum pharmacokinetics (amoxycillin 1 g iv tds or erythromycin 500 mg qds or HMR 3647 800 mg bd). Forty-eight hours of therapy with HMR 3647 and amoxycillin resulted in significant bacterial clearance in the lungs and spleen of rabbits infected by S. pneumoniae strain 195 and strain 16089 (at least 3 log(10) cfu/g decrease, P < 0.001). Erythromycin was active against only the erythromycinsusceptible strain (3 log(10) cfu/g decrease at 48 h, P < 0.001). None of the antibiotics showed significant efficacy with strain 11724. All agents produced significant bacterial clearance when time above MBC was >33%, and microbiological failure when it was <25%, whereas MIC was not correlated with microbiological outcome with HMR 3647. Our findings suggest that pharmacodynamic data integrating MBC may be predictive of microbiological success or failure with greater accuracy than with MIC. HMR 3647 produced significant bacterial clearance in both penicillin- and erythromycin-resistant pneumonia, but was less effective against the highly erythromycin-resistant S. pneumoniae strain.


Assuntos
Antibacterianos/uso terapêutico , Cetolídeos , Macrolídeos , Pneumonia Pneumocócica/tratamento farmacológico , Amoxicilina/farmacocinética , Amoxicilina/uso terapêutico , Animais , Antibacterianos/farmacocinética , Modelos Animais de Doenças , Eritromicina/farmacocinética , Eritromicina/uso terapêutico , Humanos , Masculino , Penicilinas/farmacocinética , Penicilinas/uso terapêutico , Pneumonia Pneumocócica/metabolismo , Coelhos , Streptococcus pneumoniae/efeitos dos fármacos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...